Methylergonovine maleate · METHYLERGONOVINE MALEATE .2 mg/1 · Tablet · Oral · Lupin Pharmaceuticals,Inc.
NDC 27437-0050-56 · 28 TABLET in 1 BOTTLE · ANDA · View full market →
7 companies supply this market — a reasonable cushion if one runs into trouble. The price has jumped 173% in a year, to $59.64 per unit — sharp rises like this often mean supply is already tightening.
The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.
The same NDC has different prices depending on who is paying. Units differ between rungs — compare within a rung over time, not rung against rung, unless the units match.
Each rung is the newest figure for this NDC from one federal price system, shown with its own unit. Part D is matched by drug name because CMS publishes no NDCs there; it is gross spending, before confidential rebates.
Pipeline and calculations built by Claude (Fable 5) from the public datasets above. Educational only — verify against primary sources before acting.
No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.
How Part D pricing works →Not scored — fragility is computed for NADAC-priced NDCs.
sole-source market · 1 Class I/II recall(s) in 12 months
For scale: the typical drug’s chance is about 0.1% — this one is in ordinary territory.
Backtested statistical model over the whole market, not this package alone. Model details →
Establishments this product's FDA label declares, located via FDA registration data. How we built this →
There's no legal definition — it meets 1 of 6 public criteria. Why that matters →
No FDA shortage reports for this drug or its presentations.
No enforcement reports list this package NDC.
| Labeler | Strength | First seen | Last seen |
|---|---|---|---|
| American Health Packaging | METHYLERGONOVINE MALEATE .2 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Granules Pharmaceuticals Inc. | METHYLERGONOVINE MALEATE .2 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Lupin Pharmaceuticals,Inc. | METHYLERGONOVINE MALEATE .2 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Major Pharmaceuticals | METHYLERGONOVINE MALEATE .2 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Rising Pharma Holdings, Inc. | METHYLERGONOVINE MALEATE .2 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Teva Pharmaceuticals USA, Inc. | METHYLERGONOVINE MALEATE .2 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Volley Pharmaceuticals, LLC | METHYLERGONOVINE MALEATE .2 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
Roster from daily NDC Directory diffs — first/last seen dates start July 2026.
DrugDashboards, "Methergine — NDC 27437-0050-56," retrieved September 3, 2026, https://drugdashboards.com/drug/27437005056.
Free to cite with attribution — see how the data is put together.